Forsythoside A blocks the infection of Avian Infectious Bronchitis Virus through binding S1 subunit
Shen, R.; Liu, X.; Yin, P.; Li, X.; Chu, J.; Yao, H.; Hou, X.
Show abstract
Avian infectious bronchitis (IB) is an acute highly contagious respiratory infectious disease caused by avian infectious bronchitis virus (IBV), causing serious economic losses to poultry industry. Forsythiaside A (FTA) is a phenylethanol glycoside compound in the fruit of Forsythia suspensa, which is widely used for inflammatory respiratory tract disease, including viral infected inflammation. In this study, the mechanism of FTA against IBV was researched. To determine the inhibitory effect of FTA on IBV infection and the interaction between FTA and IBV particles, immunofluorescence assay, plaque assay, RT-qPCR and enzyme-linked immunosorbent assay (ELISA) were performed and it was discovered that FTA inhibited IBV infection and viral attachment to host receptor under non-cytotoxic concentrations, and FTA may bind to virus particles. Then ELISA and isothermal titration calorimetry (ITC) were employed to further study the interaction between FTA and S protein. The results indicated that FTA bound to S1 subunit rather S2 subunit. Besides, the molecular docking showed that FTA form hydrogen bonds with eight amino acids in the S1 subunit. When these amino acids were mutated. the affinity disappeared between the S1 mutant and FTA. In conclusion, FTA prevents IBV infection by blocking viral attachment and contacts with the S1, but not the S2 subunit of IBV. At last, the bind sites were identified by comparing the affinity of wild S1 and mutant S1.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Key mutations on spike protein altering ACE2 receptor utilization and potentially expanding host range of emerging SARS-CoV-2 variants 95%
- Brilacidin, a COVID-19 Drug Candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E and NL63 through targeting both the virus and the host cell 95%
- Effects of SARS-CoV-2 Mutations on Protein Structures and Intraviral Protein-Protein Interactions 94%
Similar papers in this journal
- Efficient rescue of a newly classified Ebinur lake orthobunyavirus with GFP reporter and its application in rapid antiviral screening 96%
- DMBT1 promotes SARS-CoV-2 infection and its SRCR-derived peptide inhibits SARS-CoV-2 infection 95%
- First report of antiviral activity of nordihydroguaiaretic acid against Fort Sherman-like virus (Orthobunyavirus) 95%
Similar papers in this journal
- Reverse-transcription recombinase-aided amplification assay for H5 subtype avian influenza virus 94%
- Prediction and Evolution of B Cell Epitopes of Surface Protein in SARS-CoV-2 94%
- Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein 93%
Similar papers in this journal
- The chicken chorioallantoic membrane model for isolation of CRISPR/cas9-based HSV-1 mutant expressing tumor suppressor p53 95%
- Discovery of anti-SARS-CoV-2 S2 protein antibody CV804 with broad-spectrum reactivity with various beta coronaviruses and analysis of its pharmacological properties in vitro and in vivo 95%
- In silico analysis and in planta production of recombinant ccl21/IL1β protein and characterization of its in vitro anti-tumor and immunogenic activity 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.